| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: a observational cohort study
Authors:ID Grmec, Štefek (Author)
ID Mally, Štefan (Author)
Files:.pdf Critical_Care_2006_Grmec,_Mally_Vasopressin_improves_outcome_in_out-of-hospital_cardiopulmonary_resuscitation_of_ventricular_fibrillatio.pdf (159,29 KB)
MD5: F7EBB522A3583E4D24EFA8DEBF246AFB
 
URL http://ccforum.biomedcentral.com/articles/10.1186/cc3967
 
Language:English
Work type:Scientific work
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Abstract:Introduction: An increasing body of evidence from laboratory and clinical studies suggests that vasopressin may represent a promising alternative vasopressor for use during cardiac arrest and resuscitation. Current guidelines for cardiopulmonary resuscitation recommend the use of adrenaline (epinephrine), with vasopressin considered only as a secondary option because of limited clinical data. Method: The present study was conducted in a prehospital setting and included patients with ventricular fibrillation or pulseless ventricular tachycardia undergoing one of three treatments: group I patients received only adrenaline 1 mg every 3 minutes; group II patients received one intravenous dose of arginine vasopressine (40 IU) after three doses of 1 mg epinephrine; and patients in group III received vasopressin 40 IU as first-line therapy. The cause of cardiac arrest (myocardial infarction or other cause) was established for each patient in hospital. Results: A total of 109 patients who suffered nontraumatic cardiac arrest were included in the study. The rates of restoration of spontaneous circulation and subsequent hospital admission were higher in vasopressin-treated groups (23/53 [45%] in group I, 19/31 [61%] in group II and 17/27 [63%] in group III). There were also higher 24-hour survival rates among vasopressin-treated patients (P < 0.05), and more vasopressin-treated patients were discharged from hospital (10/51 [20%] in group I, 8/31 [26%] in group II and 7/27 [26%] group III; P = 0.21). Especially in the subgroup of patients with myocardial infarction as the underlying cause of cardiac arrest, the hospital discharge rate was significantly higher in vasopressin-treated patients (P < 0.05). Among patients who were discharged from hospital, we found no significant differences in neurological status between groups. Conclusion: The greater 24-hour survival rate in vasopressin-treated patients suggests that consideration of combined vasopressin and adrenaline is warranted for the treatment of refractory ventricular fibrillation or pulseless ventricular tachycardia. This is especially the case for those patients with myocardial infarction, for whom vasopressin treatment is also associated with a higher hospital discharge rate.
Keywords:vasopressin, antidiuretic hormone, ADH, out-of-hospital cardiopulmonary resuscitation, ventricular fibrillation, pulseless ventricular tachycardia
Publication status:Published
Publication version:Version of Record
Year of publishing:2006
Number of pages:str. 1-7
Numbering:Letn. 10
PID:20.500.12556/DKUM-66515 New window
ISSN:1466-609X
UDC:616.1
ISSN on article:1466-609X
COBISS.SI-ID:2183487 New window
DOI:10.1186/cc3967 New window
NUK URN:URN:SI:UM:DK:TC5QC4VY
Publication date in DKUM:29.06.2017
Views:2060
Downloads:215
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Critical Care
Shortened title:Crit. Care
Publisher:BioMed Central
ISSN:1466-609X
COBISS.SI-ID:1137983 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:29.06.2017

Secondary language

Language:Slovenian
Keywords:antidiuretični hormon, ADH, izvenbolnišnično oživljanje, reanimacija, prekatna fibrilacija, prekatna tahikardija brez tipnega utripa


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica